Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Kolltan Pharmaceuticals Inc.
Headquarters: New Haven, CT, United States of America
Website: N/A
Year Founded: 2007
Status: Acquired
BioCentury | Jun 23, 2023
Finance
How Apogee will test the IPO market’s appetite for preclinical risk
Backed by Fairmount Funds and Venrock and spun out of Paragon, the young start-up has an experienced CFO and is aiming for familiar targets
BioCentury | Sep 7, 2022
Management Tracks
Harpoon’s McMahon becomes CEO at Storm
Plus new CFO, CSO at Voyager and updates from Sonoma, Garuda, Alloy, Homology and more
BioCentury | Jul 9, 2021
Product Development
Comeback kid: Celldex gets latest lift from acquired urticaria program
Celldex’s KIT inhibitor is slated to enter Phase II testing next half.
Items per page:
1 - 10 of 39